Suppr超能文献

尼可地尔:对其用于稳定型心绞痛管理(包括高危患者)的综述。

Nicorandil: a review of its use in the management of stable angina pectoris, including high-risk patients.

作者信息

Simpson Dene, Wellington Keri

机构信息

Adis International Limited, Auckland, New Zealand.

出版信息

Drugs. 2004;64(17):1941-55. doi: 10.2165/00003495-200464170-00012.

Abstract

Nicorandil (Adancor, Angicor, Dancor, Nikoril [Europe], Ikorel [Europe and Oceania], Sigmart [Japan, Korea and Taiwan]) is an adenosine triphosphate (ATP)-sensitive potassium (KATP) channel agonist with nitrate-like properties used in the management of stable angina pectoris. With well established monotherapeutic antianginal activity and a beneficial effect (when added to optimal antianginal therapy) on clinical outcomes in high-risk patients with stable angina, twice-daily oral nicorandil is a useful alternative or addition to other antianginal therapy.

摘要

尼可地尔(Adancor、Angicor、Dancor、Nikoril[欧洲]、Ikorel[欧洲和大洋洲]、Sigmart[日本、韩国和台湾])是一种具有硝酸盐样特性的三磷酸腺苷(ATP)敏感性钾(KATP)通道激动剂,用于治疗稳定型心绞痛。尼可地尔每日口服两次,具有明确的单一抗心绞痛活性,且(添加至最佳抗心绞痛治疗方案时)对稳定型心绞痛高危患者的临床结局有有益影响,是其他抗心绞痛治疗的有用替代药物或补充药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验